David F. Gilmore Data-verified

Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.

Researcher

Last publication 2023 Last refreshed 2026-05-16

faculty

19 h-index 36 pubs 986 cited

Biography and Research Information

OverviewAI-generated summary

David F. Gilmore's research focuses on the design, synthesis, and evaluation of novel pyrazole derivatives as antibacterial agents. His work investigates their potency against Gram-positive bacteria, including Staphylococcus aureus and Enterococcus species, as well as Gram-negative bacteria such as Acinetobacter baumannii. Gilmore has explored structure-activity relationships, particularly concerning substituents on the phenyl rings and benzoic acid moieties, to optimize antimicrobial efficacy. His research also extends to the development of pyrazole derivatives that act as inhibitors of fatty acid biosynthesis in bacteria. Gilmore has a publication record of 36 papers, with an h-index of 19 and 977 total citations. He has collaborated with several faculty members at Arkansas State University, including Mohammad A. Alam, Hansa Raj KC, Subrata Roy, and Mohd Kotaiba Abugazleh.

Metrics

  • h-index: 19
  • Publications: 36
  • Citations: 986

Selected Publications

  • Development and Antibacterial Properties of 4-[4-(Anilinomethyl)-3-phenylpyrazol-1-yl]benzoic Acid Derivatives as Fatty Acid Biosynthesis Inhibitors (2023)
    13 citations DOI OpenAlex
  • Development of 4-[4-(Anilinomethyl)-3-phenyl-pyrazol-1-yl] Benzoic Acid Derivatives as Potent Anti-Staphylococci and Anti-Enterococci Agents (2022)
    8 citations DOI OpenAlex
  • Novel Pyrazoles As Potent Growth Inhibitors of Staphylococci, Enterococci and <i>Acinetobacter Baumannii</i> Bacteria (2021)
    11 citations DOI OpenAlex
  • Design, synthesis, and antibacterial activity of<i>N</i>-(trifluoromethyl)phenyl substituted pyrazole derivatives (2021)
    29 citations DOI OpenAlex
  • Synthesis of 3,5-Bis(trifluoromethyl)phenyl-Substituted Pyrazole Derivatives as Potent Growth Inhibitors of Drug-Resistant Bacteria (2021)
    7 citations DOI OpenAlex
  • Synthesis of Chimeric Thiazolo‐Nootkatone Derivatives as Potent Antimicrobial Agents (2021)
    23 citations DOI OpenAlex
  • 4-4-(Anilinomethyl)-3-[4-(trifluoromethyl)phenyl]-1H-pyrazol-1-ylbenzoic acid derivatives as potent anti-gram-positive bacterial agents (2021)
    25 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

21 Collaborators 3 Institutions 1 Country

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics